ArthNow Logo
ArthNow
•2 min read•
✦Reported by Economic Times

Concurrent Gainers: 9 stocks gain for 5 days in a row - Winning Streak

Concurrent Gainers: 9 stocks gain for 5 days in a row - Winning Streak
Source: Economic Times

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓Nine stocks from the BSE 200 index gained for five days in a row ending November 6.
  • ✓These companies delivered returns between 15% and 20% during the period.
  • ✓The rally followed a strong performance by the Sensex, which surged 8.82% as many stocks got a boost in the market.

Story at a Glance

Category
Indian Markets
Reported By
Economic Times
Reading Speed
2 Minute(s)
Market Focus
India Economy

Concurrent Gainers: 9 stocks gain for 5 days in a row

1/11

Winning Streak

Over the five trading sessions ending November 6, the Sensex surged 8.82%, or 6,568 points, to close at 81,028, marking gains in each of the five sessions. Amid this broad-based rally, around 45 stocks from the BSE 200 index advanced in all five consecutive sessions from November 2 to 6. Of these, we shortlisted 9 stocks that consistently gained throughout the period, delivering cumulative returns ranging from 15% to 20%. (Data Source: ACE Equity)

2/11

Muthoot Finance

5-Day Gain: 19% | Previous Close: Rs 2860

3/11

Ashok Leyland

5-Day Gain: 19% | Previous Close: Rs 172

4/11

Kalyan Jewellers India

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Economic Times

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.